The conjugation of proteins with ubiquitin involves the sequential action of proteins known as E1 (ubiquitin activating enzyme), E2s or UBCs (ubiquitin conjugating enzymes), and E3s (ubiquitin protein ligases). We have previously determined that RING finger proteins are in general ubiquitin ligases and have now focused on understanding issues related to the mechanism of action and substrates of specific members of this family as well as identifying inhibitors. Yeast two-hybrid screens carried out with Myriad Genetics have yielded a number of interesting interaction partners for E3 that include AO7 (RNF25), Ariadine and BRAP (IMP). For AO7 several of these interactions have been confirmed using a far-western approach, and in collaboration with Dr. Robert Coffey we have determined that at least one interacting protein, Naked-2 is a bona fide substrate for AO7. Further studies are currently ongoing to evaluate potential substrates for this and other E3s. Our studies looking for inhibitors of Mdm2 have resulted in the identification of a family of compounds that inhibit Mdm2 E3 activity both in vitro and in cells (HLI98 family) and we have now identified a related small molecule that is highly soluble in water and exhibits greater potency than the HLI98 compounds. This small molecule selectively kills p53-expressing cancer cells in a manner similar to the original compounds. Additionally, our screens have also resulted in the identification of an inhibitor of the ubiquitin E1 inhibitor. This inhibitor markedly deceases ubiquitin-mediated degradation of substrates as well as non-proteolytic functions of the ubiquitin system including ligand-induced activation of NfkB and ligand-mediated ubiquitination of the epidermal growth factor receptor. It also results in increased levels of p53 and in selective cell death in transformed cells expressing wild type p53. Thus, this new tool should be of great value for experimental purposes and may also serve as the basis for new therapeutics for cancer and other diseases in which perturbing functions of the ubiquitin system may be of beneficial. We are also carrying out structure-function and structural studies on the transmembrane ERAD ubiquitin ligase gp78. Preliminary results show good correlations between findings obtained from NMR (in collaboration with Dr. R. Andrew Byrd) and biochemical studies being carried out in our laboratory. These studies should provide new insights into the function of ubiquitin ligases. In addition to this we have been carrying out structure-function studies for the HRD1 ubiquitin ligase of yeast. In particular we have been focusing on an essential component of this ligase complex known as Cue1p. We have determined that a discrete region within Cue1p binds to the yeast ERAD E2 (Ubc7p) and is essential for ERAD in yeast. Interestingly the CUE domain of Cue1p appears to be dispensible. These studies in yeast complement and inform our studies in mammalian cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC010292-10
Application #
7732986
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
2008
Total Cost
$552,414
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Martin, Damali N; Boersma, Brenda J; Yi, Ming et al. (2009) Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS One 4:e4531
Kostova, Zlatka; Mariano, Jennifer; Scholz, Simone et al. (2009) A Ubc7p-binding domain in Cue1p activates ER-associated protein degradation. J Cell Sci 122:1374-81
Ding, Wei; Li, Cunxi; Hu, Tianhui et al. (2008) EGF receptor-independent action of TGF-alpha protects Naked2 from AO7-mediated ubiquitylation and proteasomal degradation. Proc Natl Acad Sci U S A 105:13433-8
Lee, Sangho; Tsai, Yien Che; Mattera, Rafael et al. (2006) Structural basis for ubiquitin recognition and autoubiquitination by Rabex-5. Nat Struct Mol Biol 13:264-71
Mattera, Rafael; Tsai, Yien Che; Weissman, Allan M et al. (2006) The Rab5 guanine nucleotide exchange factor Rabex-5 binds ubiquitin (Ub) and functions as a Ub ligase through an atypical Ub-interacting motif and a zinc finger domain. J Biol Chem 281:6874-83
Yang, Yili; Lorick, Kevin L; Jensen, Jane P et al. (2005) Expression and evaluation of RING finger proteins. Methods Enzymol 398:103-12
Megumi, Yuzuru; Miyauchi, Yasuhiro; Sakurai, Hitomi et al. (2005) Multiple roles of Rbx1 in the VBC-Cul2 ubiquitin ligase complex. Genes Cells 10:679-91
Yang, Yili; Ludwig, Robert L; Jensen, Jane P et al. (2005) Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. Cancer Cell 7:547-59
Lorick, Kevin L; Jensen, Jane P; Weissman, Allan M (2005) Expression, purification, and properties of the Ubc4/5 family of E2 enzymes. Methods Enzymol 398:54-68
Yang, Yili; Li, Chou-Chi H; Weissman, Allan M (2004) Regulating the p53 system through ubiquitination. Oncogene 23:2096-106

Showing the most recent 10 out of 13 publications